New insights into diabetes-induced cardiac pathology

Individuals with diabetes have an elevated risk of heart disease, and there is a significant clinical need for evidence-based treatments. Heart disease in diabetes manifests as a distinct cardiopathology, with cardiac structural and functional remodeling underlying increased susceptibility to cardia...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of molecular and cellular cardiology Ročník 203; s. 76 - 81
Hlavní autoři: Weeks, K.L., Bernardo, B.C., Bell, J.R., Delbridge, L.M.D., Mellor, K.M.
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Elsevier Ltd 01.06.2025
Témata:
Adeno-associated viral vector
Animals
Cardiac gene delivery
Cardiac metabolism
Diabetes Mellitus - metabolism
Diabetes Mellitus - pathology
Diabetic Cardiomyopathies - metabolism
Diabetic Cardiomyopathies - pathology
Diabetic heart disease
Epicardial adipose
Heart Diseases - etiology
Heart Diseases - metabolism
Heart Diseases - pathology
Humans
Myocardium - metabolism
Myocardium - pathology
Non-coding RNA
Cardiac gene delivery
Diabetic heart disease
Cardiac metabolism
Adeno-associated viral vector
Non-coding RNA
Epicardial adipose
ISSN:0022-2828, 1095-8584, 1095-8584
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Individuals with diabetes have an elevated risk of heart disease, and there is a significant clinical need for evidence-based treatments. Heart disease in diabetes manifests as a distinct cardiopathology, with cardiac structural and functional remodeling underlying increased susceptibility to cardiac dysfunction and arrhythmias. An understanding of the mechanisms associated with cardiac vulnerability in diabetes is incomplete, but recent studies have advanced new insights into the roles of metabolic disturbances, gene dysregulation and epicardial adipose influence. This perspective article highlights these three promising new developments in proposed mechanisms, and discusses exciting advances in cardiac-targeting for potential treatment of diabetic heart disease. •Metabolic disturbances in the diabetic heart are complex & require further investigation.•Non-coding RNAs regulate numerous processes in the diabetic heart & are potential drug targets.•Epicardial adipose is emerging as a key contributor to diabetic & other cardiac pathologies.•Novel treatment modalities hold promise for diabetic heart disease.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0022-2828
1095-8584
1095-8584
DOI:10.1016/j.yjmcc.2025.04.008